Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4652|21-9541|1|224-232

ISSN： 0021-9541

Source： JOURNAL OF CELLULAR PHYSIOLOGY, Vol.21-9541, Iss.1, 2016-01, pp. : 224-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy

By  

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 231, Iss. 1, 2016-01 ,pp. : 224-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibronectin is a serum biomarker for Duchenne muscular dystrophy

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 8, Iss. 3-4, 2014-04 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy

By  

EXPERIMENTAL PHYSIOLOGY (ELECTRONIC), Vol. 100, Iss. 12, 2015-12 ,pp. : 1458-1467

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy

By Al-Zaidy Samiah A.   Lloyd-Puryear Michele   Kennedy Annie   Lopez Veronica   Mendell Jerry R.  

International Journal of Neonatal Screening, Vol. 3, Iss. 2, 2017-04 ,pp. : 8-8

MDPI

Access to resources Recommend Favorite

Cystic fibrosis, Duchenne muscular dystrophy and preimplantation genetic disorders

By Liu J.  

Human Reproduction Update, Vol. 2, Iss. 6, 1996-11 ,pp. : 531-539

Oxford University Press

Access to resources Recommend Favorite